The Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors

Summary

This study is an open-label, phase I clinical trial of SHR-A2009 in patients with advanced solid tumors. The whole study is divided into three stages: dose escalation, dose expansion and efficacy expansion.

Timeline

Start

2022-07-21

Primary completion

2024-04-30

Completion

2024-04-30

Drugs

Indications